MedTrace Logo

Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging

NCT01717937 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2014-09-04

No results posted yet for this study

Summary

The purpose of this study is to determine whether phase variance optical coherence tomography (PV-OCT), a software-based optical coherence tomography(OCT) image processing technology, can be used to generate angiographic images of the retinochoroidal vasculature that are comparable to those produced by fluorescein angiography (FA), the current gold standard diagnostic test.

Conditions

  • Age-related Macular Degeneration
  • Diabetic Retinopathy
  • Hypertensive Retinopathy
  • Retinal Vein Occlusion
  • Retinal Artery Occlusion

Interventions

PROCEDURE

Phase variance optical coherence tomography (PV-OCT)

Subjects will undergo standard, noninvasive optical coherence tomography (OCT) scans with an FDA-approved OCT device, and the data gathered by this device will be transferred to a separate computer for processing using novel software. This software is capable of utilizing the existing data to generate phase variance OCT images. There are no known risks associated with OCT scans.

Sponsors & Collaborators

Principal Investigators

  • Scott M McClintic, M.D. · University of California, San Francisco

  • Daniel M Schwartz, M.D. · University of California, San Francisco

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01717937 on ClinicalTrials.gov